ReviewBiomolecules2026
Orphan Enzymes in the Mammalian L-Fucose Degradation Pathway.
Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Orphan enzymes are recognized and classified enzymatic activities that lack associated amino acid sequences. Since the term was coined in the mid-2000s, the proportion of orphan enzymes has substantially decreased; however, it is estimated that at least ≈900 enzymatic activities remain devoid of molecular identity to date. The putative mammalian metabolic pathway for L-fucose degradation represents a system that long consisted exclusively of orphan enzymes, with only a few recently "deorphaned" and biochemically characterized. L-Fucose is a unique monosaccharide frequently found in various glycolipids and glycoproteins synthesized by mammalian cells, such as the ABO blood group antigens in humans. While the importance of the biosynthetic pathways for its active form (GDP-L-fucose) is well established in diverse biological processes, the enzymology and physiological role of L-fucose catabolism remain largely enigmatic. In this review, we summarize the current knowledge regarding the enzymological and physiological aspects of L-fucose catabolism in mammals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.